When multiple myeloma relapses

RESPOND with a treatment with a low incidence of peripheral neuropathy

Peripheral neuropathy (grade ≥2)1

Adapted from Dimopoulos et al.1
Peripheral neuropathy included (in descending order of frequency): peripheral neuropathy, peripheral sensory neuropathy, neuralgia, decreased vibratory sense, polyneuropathy, sensory loss, amyotrophy, peripheral motor neuropathy, peripheral sensorimotor neuropathy, sensory disturbance, and toxic neuropathy.

Refer to Summary of Product Characteristics and Prescribing Information for comprehensive safety information

Frequency of AEs may vary between studies. Refer to SmPC for selected AEs reported in clinical studies.2
*In the intention-to-treat population: Kd (n=464) and Vd (n=465).

Please read the SmPC for full comprehensive safety information

References

  1. Dimopoulos MA et al. Lancet Oncol 2016;17:27–38.
  2. Kyprolis® (carfilzomib) Summary of Product Characteristics; 2016.

Terms of Use

The information contained in this site is for European healthcare professionals only.

Kyprolis